Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer

Clinical trial NCT01553656 · COMPLETED

Trial details

NCT number: NCT01553656
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Cancer NSCLC

Start date: 2011-02-01
Primary completion: 2015-05-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.